MeSH D016511 - severe combined immunodeficiency
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000081207:Primary immunodeficiency diseases
D007232:Newborn infant diseases
0 Companies
0 Drugs
Success rate
D049914:Dna repair-deficiency disorders
0 Companies
0 Drugs
Success rate
D053632:X-linked combined immunodeficiency diseases
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Leadiant Biosciences | Pegademase bovine | Adagen | 1990-03-21 |
Clinical Trials
Historical Success Rate
Phase 1
60%9/15
Phase 2
26%5/19
Phase 3
29%2/7
Approved: 1Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use